Celldex Therapeutics (CLDX) EBIT Margin Growth (5y) (2015 - 2026)
Powered by 
Analysis
Celldex Therapeutics (CLDX) EBIT Margin Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 10 | Celldex Therapeutics | 3.08 Bn | 3.08 Bn | -2.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -36.61 Mn |
| Mar 31, 2026 | -56.05 Mn |
| Dec 31, 2025 | -7.14 Mn |
| Jun 30, 2025 | -393,186.00 |
| Mar 31, 2025 | -855,553.00 |
| Dec 31, 2024 | -330,388.00 |
| Sep 30, 2024 | 53,570.00 |
| Jun 30, 2024 | -13,990.00 |
| Mar 31, 2024 | -2.48 Mn |
| Dec 31, 2023 | -46,567.00 |
| Sep 30, 2023 | -189,338.00 |
| Jun 30, 2023 | -1.18 Mn |
| Mar 31, 2023 | -41,600.00 |
| Dec 31, 2022 | -99,017.00 |
| Sep 30, 2022 | -599,041.00 |
| Jun 30, 2022 | -2.16 Mn |
| Mar 31, 2022 | -1.11 Mn |
| Dec 31, 2021 | -423,006.00 |
| Sep 30, 2021 | -1.23 Mn |
| Jun 30, 2021 | 194,396.00 |